Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Cirrhosis

Free Subscription Articles published in Hepatology Retrieve available abstracts of 223 articles: HTML format Text format

Single Articles

February 2012
1. D'AMICO G , Tine F
   Long-term low-dose maintenance pegylated interferon may prevent decompensation in cirrhotic patients with portal hypertension: Are we there yet?
   Hepatology. 2012;55:642-4.
   PubMed     Text format     Related articles   
   
   
   
   January 2012
2. HUANG HC , Wang SS, Hsin IF, Chang CC, et al
   Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
   Hepatology. 2012 Jan 30. doi: 10.1002/hep.25625.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MERCHANTE N , Rivero-Juarez A, Tellez F, Merino D, et al
   Liver stiffness predicts clinical outcome in HIV/HCV-coinfected patients with compensated liver cirrhosis.
   Hepatology. 2012 Jan 25. doi: 10.1002/hep.25616.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. FUJIWARA K , Yokosuka O
   Frequent detection of IgM anti-herpes simplex viral antibody in patients with primary biliary cirrhosis.
   Hepatology. 2012 Jan 23. doi: 10.1002/hep.25597.
   PubMed     Text format     Related articles   
   
   
   
   
5. D'AMBROSIO R , Aghemo A, Grazia Rumi M, Ronchi G, et al
   A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients.
   Hepatology. 2012 Jan 23. doi: 10.1002/hep.25606.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CORPECHOT C , Carrat F, Poujol-Robert A, Gaouar F, et al
   Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.
   Hepatology. 2012 Jan 23. doi: 10.1002/hep.25599.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. ROWE I , Armstrong M, Parker R, Houlihan D, et al
   Informed consent in surveillance for hepatocellular carcinoma in patients with cirrhosis.
   Hepatology. 2012 Jan 19. doi: 10.1002/hep.25588.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
8. SORIANO G , Roman E, Cordoba J, Torrens M, et al
   Cognitive dysfunction in cirrhosis is associated with falls. A prospective study.
   Hepatology. 2011 Dec 27. doi: 10.1002/hep.25554.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SINGAL AK , Bashar H, Anand BS, Jampana SC, et al
   Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: Exploratory analysis from UNOS database.
   Hepatology. 2011 Dec 24. doi: 10.1002/hep.25544.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. YANG YY , Tsai TH, Huang YT, Lee TY, et al
    Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinaemia in nonalcoholic steatohepatitis-cirrhotic rats.
    Hepatology. 2011 Dec 20. doi: 10.1002/hep.25534.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. FERNANDEZ J , Acevedo J, Castro M, Garcia O, et al
    Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study.
    Hepatology. 2011 Dec 20. doi: 10.1002/hep.25532.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. TREPO E , Guyot E, Ganne-Carrie N, Degre D, et al
    PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosi.
    Hepatology. 2011 Dec 12. doi: 10.1002/hep.25518.
    PubMed     Text format     Related articles   
    
    
    
    
13. TRINCHET JC , Chaffaut C, Bourcier V, Degos F, et al
    Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities.
    Hepatology. 2011;54:1987-1997.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
14. LIU L , Yannam GR, Nishikawa T, Yamamoto T, et al
    The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis.
    Hepatology. 2011 Nov 23. doi: 10.1002/hep.24815.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. SETHASINE S , Jain D, Groszmann RJ, Garcia-Tsao G, et al
    Quantitative histological-hemodynamic correlations in cirrhosis.
    Hepatology. 2011 Nov 23. doi: 10.1002/hep.24805.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MOLHO-PESSACH V , Rios JJ, Xing C, Setchell KD, et al
    Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24781.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. JOHNSTON R , Dolman G, Aithal G
    To feed or what to feed in cirrhosis?
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24771.
    PubMed     Text format     Related articles   
    
    
    
    
18. TELTSCHIK Z , Wiest R, Beisner J, Nuding S, et al
    Intestinal bacterial translocation in cirrhotic rats is related to compromised paneth cell antimicrobial host defence.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24789.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. GHANY MG , Kim HY, Stoddard A, Wright EC, et al
    Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.
    Hepatology. 2011;54:1527-1537.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. INNES HA , Hutchinson SJ, Allen S, Bhattacharyya D, et al
    Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care.
    Hepatology. 2011;54:1547-1558.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
21. TAKAHASHI T , Miura T, Nakamura J, Yamada S, et al
    Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24757.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SCHOUTEN J , Janssen H
    Reply to letter to the editor on idiopathic non cirrhotic portal hypertension.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24753.
    PubMed     Text format     Related articles   
    
    
    
    
23. KALAMBOKIS GN , Tsianos EV
    Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24751.
    PubMed     Text format     Related articles   
    
    
    
    
24. GOEL A , Ramakrishna B, Madhu K, Zachariah U, et al
    Idiopathic non cirrhotic intrahepatic portal hypertension is an on-going problem in India.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24750.
    PubMed     Text format     Related articles   
    
    
    
    
25. TSUDA M , Moritoki Y, Lian ZX, Zhang W, et al
    Biochemical and immunologic effects of rituximab in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid.
    Hepatology. 2011 Oct 17. doi: 10.1002/hep.24748.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. BERSAGLIERE A , Raduazzo I, Nardi M, Schiff S, et al
    Induced hyperammonaemia may compromise the ability to generate restful sleep in patients with cirrhosis.
    Hepatology. 2011 Oct 12. doi: 10.1002/hep.24741.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. RINELLA ME
    Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
    Hepatology. 2011;54:1118-20.
    PubMed     Text format     Related articles   
    
    
    
    
28. GUHA IN , Myers RP, Patel K, Talwalkar JA, et al
    Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?
    Hepatology. 2011;54:1454-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
29. UMEMURA T , Joshita S, Ichijo T, Yoshizawa K, et al
    HLA class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24705.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. DOI H , Iyer TK, Carpenter E, Li H, et al
    Dysfunctional B-cell activation in cirrhosis due to hepatitis C infection associated with disappearance of CD27+ B-cell population.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24689.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. CORIAT R , Mir O, Goldwasser F, Pol S, et al
    Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-PlGF inhibitor or multikinase inhibitor sorafenib?
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24688.
    PubMed     Text format     Related articles   
    
    
    
    
32. LEISE MD , Kim WR, Canterbury KM, Poterucha JJ, et al
    Diagnostic and therapeutic advances in hepatology.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24660.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
33. LLEO A , Liao J, Invernizzi P, Zhao M, et al
    IgM levels inversely correlate with cd40l promoter methylation in patients with primary biliary cirrhosis Hepatology-Ana lleo library 4-26.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24630.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. SUNG PS , Yoon SK
    Amiodarone-induced liver cirrhosis.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24627.
    PubMed     Text format     Related articles   
    
    
    
    
35. OLSON JC , Wendon JA, Kramer DJ, Arroyo V, et al
    Intensive care of the patient with cirrhosis.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24622.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. RAKOSKI MO , McCammon RJ, Piette JD, Iwashyna TJ, et al
    Burden of cirrhosis on older americans and their families: Analysis of the health and retirement study.
    Hepatology. 2011 Aug 19. doi: 10.1002/hep.24616.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. MCNALLY RJ , James PW, Ducker S, James OF, et al
    Seasonal variation in the diagnosis of primary biliary cirrhosis: Further evidence for an environmental component to etiology.
    Hepatology. 2011 Aug 8. doi: 10.1002/hep.24597.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. THABUT D , Routray C, Lomberk G, Shergill U, et al
    Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.
    Hepatology. 2011;54:573-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
39. CECCARELLI S , Panera N, Alisi A, Nobili V, et al
    Hepatic stellate cell proliferation: A potential role of PKR.
    Hepatology. 2011 Jul 28. doi: 10.1002/hep.24579.
    PubMed     Text format     Related articles   
    
    
    
    
40. TSUDA M , Ambrosini YM, Zhang W, Yang GX, et al
    Fine phenotypic and functional characterization of effector CD8(+) T cells in patients with primary biliary cirrhosis.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24526.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. BRUIX J
    Liver cancer: still a long way to go.
    Hepatology. 2011;54:1-2.
    PubMed     Text format     Related articles   
    
    
    
    
42. PATEL SM , Sweetser S
    The wet-ascitic form of tuberculous peritonitis.
    Hepatology. 2011;54:364-5.
    PubMed     Text format     Related articles   
    
    
    
    
43. JI C , Kaplowitz N, Lau MY, Kao E, et al
    Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice.
    Hepatology. 2011;54:229-39.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
44. MARABITA F , Aghemo A, De Nicola S, Rumi MG, et al
    Genetic variation in IL28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.
    Hepatology. 2011 Jun 30. doi: 10.1002/hep.24503.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. BHALA N , Angulo P, van der Poorten D, Lee E, et al
    The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study.
    Hepatology. 2011 Jun 17. doi: 10.1002/hep.24491.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. BALLESTRI S , Lonardo A, Loria P
    Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: What do they mean and do they agree?
    Hepatology. 2011;53:2142-3.
    PubMed     Text format     Related articles   
    
    
    
    
47. WHITE JS , Foreyt JP
    Two solutions in search of a problem.
    Hepatology. 2011;53:2148.
    PubMed     Text format     Related articles   
    
    
    
    
48. THOMAS JA , Pope C, Wojtacha D, Robson AJ, et al
    Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.
    Hepatology. 2011;53:2003-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. SHEN L
    More on vitamin C deficiency in mice and humans.
    Hepatology. 2011;53:2139.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
50. KALAMBOKIS GN , Tsianos EV
    Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites on beta-blockers.
    Hepatology. 2011 May 23. doi: 10.1002/hep.24439.
    PubMed     Text format     Related articles   
    
    
    
    
51. LIU T , Wang Y, Wen C, Zhang S, et al
    Stem cells or macrophages, which contribute to bone marrow cell therapy for liver cirrhosis?
    Hepatology. 2011 May 23. doi: 10.1002/hep.24431.
    PubMed     Text format     Related articles   
    
    
    
    
52. CHEN Y , Yang F, Lu H, Wang B, et al
    Characterization of fecal microbial communities in patients with liver cirrhosis.
    Hepatology. 2011 May 13. doi: 10.1002/hep.24423.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. JNL S , Jc GP, Dc V, Hla J, et al
    Idiopathic non-cirrhotic portal hypertension.
    Hepatology. 2011 May 13. doi: 10.1002/hep.24422.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. KALAMBOKIS GN , Mouzaki A, Rodi M, Pappas K, et al
    Bacterial translocation attenuates the systemic hemodynamic improvement produced by terlipressin in patients with cirrhosis.
    Hepatology. 2011 May 12. doi: 10.1002/hep.24424.
    PubMed     Text format     Related articles   
    
    
    
    
55. BERZIGOTTI A , Garcia-Tsao G, Bosch J, Grace N, et al
    Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.
    Hepatology. 2011 May 12. doi: 10.1002/hep.24418.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. MOSCHEN AR , Gerner R, Schroll A, Fritz T, et al
    A key role for pre-B-cell colony-enhancing factor in experimental hepatitis.
    Hepatology. 2011 May 12. doi: 10.1002/hep.24416.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. INVERNIZZI P
    HLA in primary biliary cirrhosis: An old story now reviving.
    Hepatology. 2011 May 11. doi: 10.1002/hep.24414.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. ANGULO P
    Diagnosing steatohepatitis and predicting liver-related mortality in nafld: Two distinct concepts.
    Hepatology. 2011 May 6. doi: 10.1002/hep.24403.
    PubMed     Text format     Related articles   
    
    
    
    
59. NGUYEN D , Talwalkar JA
    Diagnostic and therapeutic advances in Hepatology noninvasive assessment of liver fibrosis.
    Hepatology. 2011 May 5. doi: 10.1002/hep.24401.
    PubMed     Text format     Related articles   
    
    
    
    
60. AGUSTIN A , Javier Z
    Beta-blockers in patients with cirrhosis and refractory ascites.
    Hepatology. 2011;53:1783.
    PubMed     Text format     Related articles   
    
    
    
    
61. STEENKISTE CV , Ribera J, Geerts A, Pauta M, et al
    Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice.
    Hepatology. 2011;53:1629-40.
    PubMed     Text format     Related articles   
    
    
    
    
62. HARTMANN D , Srivastava U, Thaler M, Kleinhans KN, et al
    Telomerase gene mutations are associated with cirrhosis formation.
    Hepatology. 2011;53:1608-17.
    PubMed     Text format     Related articles   
    
    
    
    
63. CALADO RT , Brudno J, Mehta P, Kovacs JJ, et al
    Constitutional telomerase mutations are genetic risk factors for cirrhosis.
    Hepatology. 2011;53:1600-7.
    PubMed     Text format     Related articles   
    
    
    
    
64. CHU AS , Diaz R, Hui JJ, Yanger K, et al
    Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis.
    Hepatology. 2011;53:1685-95.
    PubMed     Text format     Related articles   
    
    
    
    
65. DEGOS F , Lebrun L, Perez P, Durand-Zaleski I, et al
    Methods and interest of noninvasive assessment of liver fibrosis are still in debate.
    Hepatology. 2011;53:1781.
    PubMed     Text format     Related articles   
    
    
    
    
66. TSOCHATZIS EA , Germani G, Hall A, Anousou PM, et al
    Noninvasive assessment of liver fibrosis: the need for better validation.
    Hepatology. 2011;53:1781-2.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
67. BANSAL R , Prakash J, Post E, Beljaars L, et al
    A novel engineered targeted interferon gamma blocks hepatic fibrogenesis in mice.
    Hepatology. 2011 Apr 29. doi: 10.1002/hep.24395.
    PubMed     Text format     Related articles   
    
    
    
    
68. LAI JC , Verna EC, Brown RS Jr, O'Leary JG, et al
    Hepatitis C virus infected females have a higher risk of advanced fibrosis and graft loss after liver transplantation than males.
    Hepatology. 2011 Apr 28. doi: 10.1002/hep.24390.
    PubMed     Text format     Related articles   
    
    
    
    
69. TARRATS N , Moles A, Morales A, Garcia-Ruiz C, et al
    Critical role of TNF-receptor 1 but not 2 in hepatic stellate cell proliferation, extracellular matrix remodeling and liver fibrogenesis.
    Hepatology. 2011 Apr 26. doi: 10.1002/hep.24388.
    PubMed     Text format     Related articles   
    
    
    
    
70. RONG G , Zhong R, Lleo A, Leung PS, et al
    Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24355.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. SCHILDBERG FA , Wojtalla A, Siegmund SV, Endl E, et al
    Hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24352.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. TREPO E , Pradat P, Potthoff A, Momozawa Y, et al
    Impact of PNPLA3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24350.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. XIN YN , Lin ZH, Xuan SY
    Are there more factors other than hepatitis B virus-DNA level and A1762T/G1764A mutation in liver tissue that also independently predict postoperative survival in hepatocellular carcinoma?
    Hepatology. 2011 Apr 5. doi: 10.1002/hep.24211.
    PubMed     Text format     Related articles   
    
    
    
    
74. WU JW , Wang SP, Alvarez F, Casavant S, et al
    Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.
    Hepatology. 2011 Apr 4. doi: 10.1002/hep.24338.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. GALBOIS A , Das V, Thabut D, Maury E, et al
    Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections.
    Hepatology. 2011;53:1412-3.
    PubMed     Text format     Related articles   
    
    
    
    
76. KURT M
    Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
    Hepatology. 2011;53:1411-2.
    PubMed     Text format     Related articles   
    
    
    
    
77. GALICHON P , Hertig A, Rondeau E, Mesnard L, et al
    Warning: Genome-wide association studies can be misleading. An example in hepatology.
    Hepatology. 2011;53:1408.
    PubMed     Text format     Related articles   
    
    
    
    
78. JEONG WI , Park O, Suh YG, Byun JS, et al
    Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice.
    Hepatology. 2011;53:1342-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. ZHANG D , Utsumi T, Huang HC, Gao L, et al
    Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis.
    Hepatology. 2011;53:1306-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. KIREVA T , Erhardt A, Tiegs G, Tilg H, et al
    Transcription factor Fra-1 induces cholangitis and liver fibrosis.
    Hepatology. 2011;53:1287-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. DI BISCEGLIE AM , Stoddard AM, Dienstag JL, Shiffman ML, et al
    Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
    Hepatology. 2011;53:1100-1108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
82. ZEMTSOVA I , Gorg B, Keitel V, Bidmon HJ, et al
    Microglia activation in hepatic encephalopathy.
    Hepatology. 2011 Mar 30. doi: 10.1002/hep.24326.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. CHAITEERAKIJ R , Roberts LR
    Telomerase mutation: A genetic risk factor for cirrhosis.
    Hepatology. 2011 Mar 21. doi: 10.1002/hep.24304.
    PubMed     Text format     Related articles   
    
    
    
    
84. VLACHOGIANNAKOS J , Daikos G, Thalheimer U, Burroughs A, et al
    Is bacterial DNA a better marker of bacterial translocation than endotoxin in decompensated cirrhosis?
    Hepatology. 2011 Mar 21. doi: 10.1002/hep.24303.
    PubMed     Text format     Related articles   
    
    
    
    
85. GAO B , Bertola A
    Natural killer cells take two tolls to destruct bile ducts.
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24275.
    PubMed     Text format     Related articles   
    
    
    
    
86. PAIK YH , Iwaisako K, Seki E, Inokuchi S, et al
    The nicotinamide adenine dinucleotide phosphate oxidase homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24281.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. BOSOI CR , Parent-Robitaille C, Anderson K, Tremblay M, et al
    AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile-duct ligated rats.
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24273.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. MOSCHEN AR , Fritz T, Clouston AD, Rebhan I, et al
    IL-32: A new proinflammatory cytokine involved in HCV-related liver inflammation and fibrosis.
    Hepatology. 2011 Mar 4. doi: 10.1002/hep.24285.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. LO GH
    Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites.
    Hepatology. 2011;53:1068-9.
    PubMed     Text format     Related articles   
    
    
    
    
90. LEWINDON PJ , Ramm GA
    Cystic fibrosis-cirrhosis, portal hypertension, and liver biopsy: Reply.
    Hepatology. 2011;53:1065-6.
    PubMed     Text format     Related articles   
    
    
    
    
91. GOMEZ-HURTADO I , Zapater P, Bellot P, Pascual S, et al
    Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis.
    Hepatology. 2011;53:935-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. WU SJ , Yang YH, Tsuneyama K, Leung PS, et al
    Innate immunity and primary biliary cirrhosis: Activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis.
    Hepatology. 2011;53:915-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. YE LP , Mao XL
    Is achievement of sustained virologic response an independent predictor or a cofactor for the development of esophageal varices?
    Hepatology. 2011;53:1070-1.
    PubMed     Text format     Related articles   
    
    
    
    
94. WITTERS P , Libbrecht L, Roskams T, Boeck KD, et al
    Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease.
    Hepatology. 2011;53:1064-5.
    PubMed     Text format     Related articles   
    
    
    
    
95. WAGNER M , Zollner G, Trauner M
    Nuclear receptors in liver disease.
    Hepatology. 2011;53:1023-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
96. YOUNOSSI Z , Stepanova M, Rafiq N, Makhlouf H, et al
    Pathologic criteria for non-alcoholic steatohepatitis (NASH): Inter-protocol agreement and ability to predict liver-related mortality.
    Hepatology. 2011 Feb 28. doi: 10.1002/hep.24268.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. CORRADINI SG , Burza MA, Molinaro A, Romeo S, et al
    Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma.
    Hepatology. 2011 Feb 23. doi: 10.1002/hep.24244.
    PubMed     Text format     Related articles   
    
    
    
    
98. SHIMODA S , Harada K, Niiro H, Shirabe K, et al
    Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.
    Hepatology. 2011 Feb 14. doi: 10.1002/hep.24194.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. THABUT D , Moreau R, Lebrec D
    Noninvasive assessment of portal hypertension in patients with cirrhosis.
    Hepatology. 2011;53:683-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. MONTAGNESE S , Biancardi A, Schiff S, Carraro P, et al
     Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.
     Hepatology. 2011;53:558-66.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. DHIRAPONG A , Lleo A, Yang GX, Tsuneyama K, et al
     B cell depletion therapy exacerbates murine primary biliary cirrhosis.
     Hepatology. 2011;53:527-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. NELSON JE , Wilson L, Brunt EM, Yeh MM, et al
     Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.
     Hepatology. 2011;53:448-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. JONES DE , Newton JL
     The complexity of fatigue.
     Hepatology. 2011;53:717-8.
     PubMed     Text format     Related articles   
     
     
     
     January 2011
104. SENZOLO M , Nadal E, Cholongitas E, Burroughs AK, et al
     Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?
     Hepatology. 2011 Jan 10. doi: 10.1002/hep.24176.
     PubMed     Text format     Related articles   
     
     
     
     
105. WENG H , Li H, Dooley S
     Inflammation does not always kill hepatocytes during liver damage.
     Hepatology. 2011 Jan 10. doi: 10.1002/hep.24166.
     PubMed     Text format     Related articles   
     
     
     
     
106. JONES DE , Mells G
     The genetics of primary biliary cirrhosis: The revolution moves on.
     Hepatology. 2011;53:362-4.
     PubMed     Text format     Related articles   
     
     
     
     
107. TAM J , Liu J, Mukhopadhyay B, Cinar R, et al
     Endocannabinoids in liver disease.
     Hepatology. 2011;53:346-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. MARTINEZ SM , Crespo G, Navasa M, Forns X, et al
     Noninvasive assessment of liver fibrosis.
     Hepatology. 2011;53:325-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. LEWINDON PJ , Shepherd RW, Walsh MJ, Greer RM, et al
     Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy.
     Hepatology. 2011;53:193-201.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. STICKEL F , Buch S, Lau K, zu Schwabedissen HM, et al
     Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.
     Hepatology. 2011;53:86-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. CHAU BN , Brenner DA
     What goes up must come down: the emerging role of microRNA in fibrosis.
     Hepatology. 2011;53:4-6.
     PubMed     Text format     Related articles   
     
     
     
     
112. RODERBURG C , Urban GW, Bettermann K, Vucur M, et al
     Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
     Hepatology. 2011;53:209-18.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
113. LO GH
     Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
114. YOON SM , Gerasimidou D, Kuwahara R, Hytiroglou P, et al
     Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans.
     Hepatology. 2010 Dec 14. doi: 10.1002/hep.24122.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. VALENTI L , Rumi M, Galmozzi E, Aghemo A, et al
     Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
     Hepatology. 2010 Dec 13. doi: 10.1002/hep.24123.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. LIN ZH , Xin YN, Dong QJ, Wang Q, et al
     Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis.
     Hepatology. 2010 Dec 7. doi: 10.1002/hep.24105.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. MACARON C , Hanouneh IA, Zein NN
     Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
     Hepatology. 2010;52:2240.
     PubMed     Text format     Related articles   
     
     
     
     
118. UBEDA M , Munoz L, Borrero MJ, Diaz D, et al
     Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis.
     Hepatology. 2010;52:2086-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. MACARON C , Hanouneh IA, Zein NN
     Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
     Hepatology. 2010;52:2240.
     PubMed     Text format     Related articles   
     
     
     
     
120. UBEDA M , Munoz L, Borrero MJ, Diaz D, et al
     Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis.
     Hepatology. 2010;52:2086-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. CLIFFORD RJ , Zhang J, Meerzaman DM, Lyu MS, et al
     Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.
     Hepatology. 2010;52:2034-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. DUSEJA A , Sharma B, Kumar A, Kapil S, et al
     Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.
     Hepatology. 2010;52:2248-9.
     PubMed     Text format     Related articles   
     
     
     
     November 2010
123. TALWALKAR JA
     Time trends in hospitalization and discharge status for cirrhosis and portal hypertension in the united states.
     Hepatology. 2010;52:1862.
     PubMed     Text format     Related articles   
     
     
     
     
124. TALWALKAR JA
     Defining the quality characteristics of endoscopy for acute variceal hemorrhage in cirrhosis.
     Hepatology. 2010;52:1850-1.
     PubMed     Text format     Related articles   
     
     
     
     
125. ROSSLE M , Grandt D
     Early transjugular intrahepatic portosystemic shunt in patients with cirrhosis and variceal bleeding.
     Hepatology. 2010;52:1847-50.
     PubMed     Text format     Related articles   
     
     
     
     
126. YU JH , Zhu BM, Wickre M, Riedlinger G, et al
     The transcription factors signal transducer and activator of transcription 5A (STAT5A) and STAT5B negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and Cdkn1a expression.
     Hepatology. 2010;52:1808-18.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. KARLMARK KR , Zimmermann HW, Roderburg C, Gassler N, et al
     The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
     Hepatology. 2010;52:1769-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. THERNEAU T
     Working with a gold-plated standard.
     Hepatology. 2010;52:1527.
     PubMed     Text format     Related articles   
     
     
     
     October 2010
129. GALBOIS A , Das V, Thabut D, Maury E, et al
     Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
130. KURT M
     Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
131. MONTAGNESE S , Biancardi A, Schiff S, Carraro P, et al
     Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. DHIRAPONG A , Lleo A, Yang GX, Tsuneyama K, et al
     B cell depletion therapy exacerbates murine primary biliary cirrhosis.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. ALBILLOS A , Zamora J
     Beta-blockers in patients with cirrhosis and refractory ascites.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
134. YU LX , Yan HX, Liu Q, Yang W, et al
     Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.
     Hepatology. 2010;52:1322-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
135. KORNEK M , Popov Y, Libermann TA, Afdhal NH, et al
     Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. SYN WK , Choi SS, Liaskou E, Karaca GF, et al
     Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. JIN Z , Sun R, Wei H, Gao X, et al
     Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. ROSSI S , Ravetta V, Rosa L, Ghittoni G, et al
     Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. WONG F , Salerno F
     Beta-blockers in cirrhosis: Friend and foe?
     Hepatology. 2010;52:811-3.
     PubMed     Text format     Related articles   
     
     
     
     
140. NUNEZ M
     Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.
     Hepatology. 2010;52:1143-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. NEUSCHWANDER-TETRI BA , Clark JM, Bass NM, Van Natta ML, et al
     Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
     Hepatology. 2010;52:913-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
142. BELLOT P , Garcia-Pagan JC, Frances R, Abraldes JG, et al
     Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. CHO IJ , Kim YW, Han CY, Kim EH, et al
     E-cadherin antagonizes transforming growth factor beta1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. KO KS , Tomasi ML, Iglesias-Ara A, French BA, et al
     Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. IAVARONE M , Sangiovanni A, Forzenigo LV, Massironi S, et al
     Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: The importance of tumor cell differentiation.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. EFE C , Purnak T, Ozaslan E
     The deleterious effects of propranolol on patients with cirrhosis.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
147. SOLA E , Lens S, Guevara M, Martin-Llahi M, et al
     Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. AL-HARTHY N , Kumagi T, Coltescu C, Hirschfield GM, et al
     The specificity of fatigue in primary biliary cirrhosis: Evaluation of a large clinic practice.
     Hepatology. 2010;52:562-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. RIGAMONTI C , Francesca Donato M, Colombo M
     Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation.
     Hepatology. 2010;52:800-1.
     PubMed     Text format     Related articles   
     
     
     
     
150. TUYAMA AC , Hong F, Saiman Y, Wang C, et al
     Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: Implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis.
     Hepatology. 2010;52:612-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. AFZALI A , Weiss NS, Boyko EJ, Ioannou GN, et al
     Association between serum uric acid level and chronic liver disease in the United States.
     Hepatology. 2010;52:578-89.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. JAGAVELU K , Routray C, Shergill U, O'Hara SP, et al
     Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver.
     Hepatology. 2010;52:590-601.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
153. KRAG A , Bendtsen F, Moller S
     Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
154. THEVENOT T , Cervoni JP, Monnet E, Sheppard F, et al
     Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
155. GHITTONI G , Caturelli E, Rossi S
     Noninvasive diagnostic criteria for hepatocellular carcinoma: A boat that leaks like a sieve.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
156. OZASLAN E
     Drug-induced autoimmune hepatitis: An easily reversible type of liver fibrosis?
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
157. ALISI A , Manco M, Pezzullo M, Nobili V, et al
     Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis1.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
158. GORG B , Qvartskhava N, Bidmon HJ, Palomero-Gallagher N, et al
     Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy.
     Hepatology. 2010;52:256-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. JURAN BD , Atkinson EJ, Larson JJ, Schlicht EM, et al
     Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene-gene interaction.
     Hepatology. 2010;52:223-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. SILVEIRA MG , Brunt EM, Heathcote J, Gores GJ, et al
     American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis.
     Hepatology. 2010;52:349-59.
     PubMed     Text format     Related articles   
     
     
     
     
161. TRIPODI A , Primignani M, Lemma L, Chantarangkul V, et al
     Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method.
     Hepatology. 2010;52:249-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. HUEBERT RC , Vasdev MM, Shergill U, Das A, et al
     Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis.
     Hepatology. 2010;52:238-48.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. DAVILA JA , Morgan RO, Richardson PA, Du XL, et al
     Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.
     Hepatology. 2010;52:132-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. VARELA-REY M , Martinez-Lopez N, Fernandez-Ramos D, Embade N, et al
     Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.
     Hepatology. 2010;52:105-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. ZHANG W , Tsuda M, Yang GX, Tsuneyama K, et al
     Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
     Hepatology. 2010;52:215-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. CHOI SS , Witek RP, Yang L, Omenetti A, et al
     Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells.
     Hepatology. 2010;52:278-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
167. KUIPER EM , van Erpecum KJ, Beuers U, Hansen BE, et al
     The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: Results of a double-blind, randomized, placebo-controlled trial.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. KAIMORI A , Potter JJ, Choti M, Ding Z, et al
     Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. HUANG YW , Hu JT, Yang SS
     Complications of alcoholic liver cirrhosis: Active assessment by endoscopy and sonography.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
170. KOHLI R , Kirby M, Xanthakos SA, Softic S, et al
     High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. DE MINICIS S , Seki E, Paik YH, Osterreicher CH, et al
     Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. BOSCH J
     Carvedilol for portal hypertension in patients with cirrhosis.
     Hepatology. 2010;51:2214-8.
     PubMed     Text format     Related articles   
     
     
     
     
173. LA MURA V , Abraldes JG, Berzigotti A, Erice E, et al
     Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
     Hepatology. 2010;51:2108-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. STEIB CJ , Bilzer M, op den Winkel M, Pfeiler S, et al
     Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.
     Hepatology. 2010;51:2086-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. MCGUIRE BM , Zupanets IA, Lowe ME, Xiao X, et al
     Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.
     Hepatology. 2010;51:2077-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. VILANA R , Forner A, Bianchi L, Garcia-Criado A, et al
     Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.
     Hepatology. 2010;51:2020-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. STERLING RK
     Long-term effects of sustained virologic response on the development of esophageal varices in compensated cirrhosis: "is the bang worth the buck?".
     Hepatology. 2010;51:1891-3.
     PubMed     Text format     Related articles   
     
     
     
     
178. IKURA Y , Iwasa Y, Ueda M
     Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.
     Hepatology. 2010;51:2227-8.
     PubMed     Text format     Related articles   
     
     
     
     
179. BURROUGHS AK , Thalheimer U
     Hepatic venous pressure gradient in 2010: optimal measurement is key.
     Hepatology. 2010;51:1894-6.
     PubMed     Text format     Related articles   
     
     
     
     
180. LLEO A , Bowlus CL, Yang GX, Invernizzi P, et al
     Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. CHANG TT , Liaw YF, Wu SS, Schiff E, et al
     Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. SHEN L
     Vitamin D controls T cell activation: Implication for causal association between vitamin D deficiency and fibrosis in chronic hepatitis C.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     May 2010
183. SERSTE T , Melot C, Francoz C, Durand F, et al
     Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. SENTURK S , Mumcuoglu M, Gursoy-Yuzugullu O, Cingoz B, et al
     Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
185. DECHENE A , Sowa JP, Gieseler RK, Jochum C, et al
     Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. ALTINBAS A , Coban S, Yuksel O
     Fibrosis in liver as a predictive marker for hepatitis C virus therapy.
     Hepatology. 2010;51:1858.
     PubMed     Text format     Related articles   
     
     
     
     
187. STARLEY BQ , Calcagno CJ, Harrison SA
     Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
     Hepatology. 2010;51:1820-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. ZEIN CO
     Clearing the smoke in chronic liver diseases.
     Hepatology. 2010;51:1487-90.
     PubMed     Text format     Related articles   
     
     
     
     
189. DAS K , Das K, Mukherjee PS, Ghosh A, et al
     Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.
     Hepatology. 2010;51:1593-602.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
190. JEPSEN P , Ott P, Andersen PK, Sorensen HT, et al
     Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.
     Hepatology. 2010;51:1675-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. PARK JK , Ki MR, Lee HR, Hong IH, et al
     Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice.
     Hepatology. 2010;51:1766-77.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
192. BERRY PA , Antoniades CG, Wendon J
     Importance of the compensatory anti-inflammatory response following severe sepsis on cirrhosis.
     Hepatology. 2010;51:1469-70.
     PubMed     Text format     Related articles   
     
     
     
     
193. ZHANG DW , Bian H
     No contribution to liver fibrosis, but possible carcinogenesis?
     Hepatology. 2010;51:1468-9.
     PubMed     Text format     Related articles   
     
     
     
     
194. VALENTI L , Al-Serri A, Daly AK, Galmozzi E, et al
     Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
     Hepatology. 2010;51:1209-17.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
195. DRANOFF JA , Wells RG
     Portal fibroblasts: Underappreciated mediators of biliary fibrosis.
     Hepatology. 2010;51:1438-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. ZALDIVAR MM , Pauels K, von Hundelshausen P, Berres ML, et al
     CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis.
     Hepatology. 2010;51:1345-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
197. GERMANI G , Dhillon A, Andreana L, Calvaruso V, et al
     Histological subclassification of cirrhosis.
     Hepatology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
198. SOBREVALS L , Rodriguez C, Romero-Trevejo JL, Gondi G, et al
     Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats.
     Hepatology. 2010;51:912-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
199. LIN WR , Lim SN, McDonald SA, Graham T, et al
     The histogenesis of regenerative nodules in human liver cirrhosis.
     Hepatology. 2010;51:1017-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
200. WELLS RG
     The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow?
     Hepatology. 2010;51:737-40.
     PubMed     Text format     Related articles   
     
     
     
     February 2010
201. LENOS MG , Tsaniklidou SM
     Comment on "Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice".
     Hepatology. 2010;51:718.
     PubMed     Text format     Related articles   
     
     
     
     
202. ADAMS L
     Transient elastography in nonalcoholic fatty liver disease: making sense of echoes.
     Hepatology. 2010;51:370-2.
     PubMed     Text format     Related articles   
     
     
     
     January 2010
203. DAVIT-SPRAUL A , Fabre M, Branchereau S, Baussan C, et al
     ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
204. WALKER NM , Stuart KA, Ryan RJ, Desai S, et al
     Serum ferritin concentration predicts mortality in patients awaiting liver transplantation.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
205. BRUNO S , Crosignani A, Facciotto C, Rossi S, et al
     Sustained virologic response prevents the development of esophageal varices in compensated, child-pugh class a hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
206. ASCHA MS , Hanouneh IA, Lopez R, Tamimi TA, et al
     The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
     Hepatology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
207. BOYER TD
     Tolvaptan and hyponatremia in a patient with cirrhosis.
     Hepatology. 2010;51:699-702.
     PubMed     Text format     Related articles   
     
     
     
     December 2009
208. PETTA S , Camma C, Scazzone C, Tripodo C, et al
     Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2009
209. GARCIA-TSAO G , Friedman S, Iredale J, Pinzani M, et al
     Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
     
210. BLAAS L , Kornfeld JW, Schramek D, Musteanu M, et al
     Disruption of the growth hormone-Signal transducer and activator of transcription 5-Insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
211. APPENRODT B , Grunhage F, Gentemann MG, Thyssen L, et al
     Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
212. MORENO M , Chaves JF, Sancho-Bru P, Ramalho F, et al
     Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
213. MORENO M , Gonzalo T, Kok RJ, Sancho-Bru P, et al
     Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2009
214. CARRION JA , Torres F, Crespo G, Miquel R, et al
     Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
215. TAURA K , Miura K, Iwaisako K, Osterreicher CH, et al
     Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2009
216. EVERHART JE , Wright EC, Goodman ZD, Dienstag JL, et al
     Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
     Hepatology. 2009;51:585-594.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
217. MODI AA , Feld JJ, Park Y, Kleiner DE, et al
     Increased caffeine consumption is associated with reduced hepatic fibrosis.
     Hepatology. 2009;51:201-209.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
218. RODERFELD M , Rath T, Voswinckel R, Dierkes C, et al
     Bone marrow transplantation demonstrates medullar origin of CD34(+) fibrocytes and ameliorates hepatic fibrosis in Abcb4(-/-) mice.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
219. WONG VW , Vergniol J, Wong GL, Foucher J, et al
     Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
     Hepatology. 2009;51:454-462.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
220. RATZIU V , Charlotte F, Bernhardt C, Giral P, et al
     Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2009
221. OSAWA Y , Seki E, Adachi M, Suetsugu A, et al
     Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
222. QI X , Han G, Fan D
     The preferable treatment for cirrhotic portal vein thrombosis: Anticoagulation or transjugular intrahepatic portosystemic shunt?
     Hepatology. 2009;51:713-714.
     PubMed     Text format     Related articles   
     
     
     
     July 2009
223. RASHID M , Mitchell JD, Cramp ME, Cross TJ, et al
     Limitations of the algorithm for the SAFE biopsy: A noninvasive fibrosis measure in chronic hepatitis C.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: